Food and Drug Administration, HHS.
The Food and Drug Administration (FDA) is publishing a list of information collections that have been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.
Start Further Info
FOR FURTHER INFORMATION CONTACT:
Ila S. Mizrachi, Office of Operations, Food and Drug Administration, Three White Flint North, 10A-12M, 11601 Landsdown St., North Bethesda, MD 20852, 301-796-7726, PRAStaff@fda.hhs.gov.
End Further Info
Start Supplemental Information
The following is a list of FDA information collections recently approved by OMB under section 3507 of the Paperwork Reduction Act of 1995 (44 U.S.C. 3507). The OMB control number and expiration date of OMB approval for each information collection are shown in table 1. Copies of the supporting statements for the information collections are available on the internet at http://www.reginfo.gov/public/do/PRAMain. An Agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number.
Table 1—List of Information Collections Approved By OMB
|Title of collection||OMB Control
|Obtaining Information to Understand Challenges and Opportunities Encountered by Compounding Outsourcing Facilities||0910-0883||1/31/2021|
|Protection of Human Subjects; Informed Consent; and Institutional Boards||0910-0130||1/31/2023|
|Biological Products: Reporting and Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Deviations in Manufacturing||0910-0458||1/31/2023|
|Reporting Associated with Designated New Animal Drugs for Minor Use and Minor Species||0910-0605||1/31/2023|
|Evaluation of the Food and Drug Administration's General Market Youth Tobacco Prevention Campaign||0910-0753||1/31/2023|
|Collection of Conflict of Interest Information for Participation in Food and Drug Administration Non-Employee Fellowship and Traineeship Programs||0910-0882||1/31/2023|
|Human Tissue Intended for Transplantation||0910-0302||2/28/2023|
|General Licensing Provisions: Biologics License Application, Changes to an Approved Application, Labeling, Revocation and Suspension, Postmarketing Studies Status Reports, and Form FDA 356h||0910-0338||2/28/2023|
|Procedures for the Safe Processing and Importing of Fish and Fishery Products||0910-0354||2/28/2023|
|Medical Devices; Shortages Data Collection System||0910-0491||2/28/2023|
|Focus Groups About Drug Products as Used by the Food and Drug Administration||0910-0677||2/28/2023|
|Start Printed Page 15188|
|Unique Device Identification System||0910-0720||2/28/2023|
|Animal Feed Regulatory Program Standards||0910-0760||2/28/2023|
End Supplemental Information
Dated: March 11, 2020.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2020-05354 Filed 3-16-20; 8:45 am]
BILLING CODE 4164-01-P